OBJECTIVE. To evaluate inhaled technosphere insulin (TI) in children with diabetes.RESEARCH DESIGN AND METHODS. 230 youth 4–17 years old with type 1 (98%)

YouTube video by Diabetes Nerd

Academy President Michael X. Repka, MD, MBA, began introduces three of her treasured colleagues: Roy W. Beck, MD, PhD; John M. Haley, MD; and David L. Guyton, MD.

OBJECTIVE. The Centers for Medicare & Medicaid Services (CMS) requires a low C-peptide level for insulin pump coverage unless the individual is β-cell

%

This Medical News article is an interview with pulmonologist Michael Welsh, MD, the co-recipient of the 2025 Lasker-DeBakey Clinical Medical Research Award for his research on cystic fibrosis.

Isaacs, Bellini, and Levy discuss a currently recruiting trial investigating CGM metrics in pregnant individuals with type 1 diabetes.

Objective: To evaluate the accuracy of the Dexcom G6 Pro continuous glucose monitoring (CGM) system in the intensive care unit (ICU) setting. Methods: We performed a prospective, observational, multicenter study in adult ICU patients with a known diagnosis of diabetes or stress hyperglycemia who were being treated with insulin. Two Dexcom G6 Pro sensors were placed. Sensor accuracy was assessed by pairing sensor and blood glucose (BG) measurements obtained as a part of usual ICU care. Accuracy of the G6 Pro also was assessed concurrently in non-ICU hospitalized individuals. Results: A total of 130 participants were enrolled, with mean (±SD) age of 62 ± 12 years, and preexisting diabetes was present in 73% and stress hyperglycemia in 27%. A total of 9120 sensor-BG pairs were analyzed. The mean relative absolute difference (RAD) was 23% (median 19%), with a mean difference of +25 mg/dL (median 25 mg/dL). Forty-one percent of sensor glucose values were within 15% of BG values for BG values ≥100 mg/dL or within 15 mg/dL of BG values for BG values <100 mg/dL, 53% within 20%/20 mg/dL, and 72% within 30%/30 mg/dL. For the two sensors worn simultaneously, the mean absolute difference was 24 mg/dL (median 19 mg/dL) and the mean RAD was 14% (median 11%). In the non-ICU setting (N = 60; 1318 sensor-BG pairs), the mean difference was 24 mg/dL (median 21 mg/dL) and the mean RAD was 21% (median 17%). Conclusions: Accuracy of the Dexcom G6 Pro sensor in the ICU setting was worse than has previously been reported for this sensor, with sensor values tending to be biased high. However, this appears to be a function of the G6 Pro sensor and not the setting as similar results were obtained in a non-ICU setting. Results should not be generalized to the real-time G6 or other sensors.

Researchers and diabetes in pregnancy investigators say they opened an observational study of automated insulin delivery (AID) in pregnancy.

To examine the overall state of metabolic control and current use of advanced diabetes technologies in the U.S., we report recent data collected on individ

To report the change in refractive error over 5 years after primary intraocular lens (IOL) placement by age at surgery and to identify factors associated with the change in refractive error after 5 ye...

OBJECTIVE. Continuous glucose monitoring (CGM) measures could be a surrogate for stimulated C-peptide outcomes in type 1 diabetes trials.RESEARCH DESIGN AN

Objective: To evaluate the accuracy of Dexcom G7 continuous glucose monitor (CGM) in the intensive care unit (ICU) setting. Methods: We performed a prospective, single-center study in patients with kn...

Introduction: The Virtual Diabetes Specialty Clinic (VDiSC) study demonstrated the feasibility of providing comprehensive diabetes care entirely virtually by co...

s. Methods: Cultivated autologous limbal epithelial cell grafts were produced in a 2-stage manufacturing process following a good manufacturing process-compliant protocol. AS-OCT and IVCM were comp...